Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.51 +0.44 (+596.85%)
As of: Aug 21, 2026 · 9:30 AM EDT

Mosaic ImmunoEngineering (CPMV) Work In Process (2011)

Mosaic ImmunoEngineering (CPMV) posted quarterly Work In Process of $36898.0 for Q4 2011, down 69.84% quarter-over-quarter from $122360.0 in Q3 2011.

Mosaic ImmunoEngineering (CPMV) Work In Process (2011) Analysis & Trends

Mosaic ImmunoEngineering's Work In Process history runs 1 years deep, the most recent figure standing at $36898.0 for Q4 2011.

  • In Q4 2011, Work In Process changed N/A year-over-year to $36898.0; the TTM figure through Nov 2011 stood at $36898.0 (changed N/A YoY), while the FY2011 annual figure was $30581.0, changed N/A from the prior year.
  • Work In Process for Q4 2011 stood at $36898.0, down from $122360.0 in the prior quarter.
  • The five-year high for Work In Process was $122360.0 in Q3 2011, with the low at $30581.0 in Q2 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Mosaic ImmunoEngineering 3.68 Mn 3.68 Mn -

Historic Data

Download Data
DateValue
Nov 30, 2011 36,898.00
Aug 31, 2011 122,360.00
May 31, 2011 30,581.00